Physiological and pathological functions of TMEM106B: a gene associated with brain aging and multiple brain disorders.

Abstract

TMEM106B, encoding a lysosome membrane protein, has been recently associated with brain aging, hypomyelinating leukodystrophy and multiple neurodegenerative diseases, such as frontotemporal lobar degeneration (FTLD) and limbic-predominant age-related TDP-43 encephalopathy (LATE). During the past decade, considerable progress has been made towards our understanding of the cellular and physiological functions of TMEM106B. TMEM106B regulates many aspects of lysosomal function, including lysosomal pH, lysosome movement, and lysosome exocytosis. Both an increase and decrease in TMEM106B levels result in lysosomal abnormalities. In mouse models,TMEM106B deficiency leads to lysosome trafficking and myelination defects and FTLD relatedpathology. In humans, alterations in TMEM106B levels or functionare intimately linked to neuronal proportions, brain aging, and brain disorders. Further elucidation of the physiological function of TMEM106B and changes inTMEM106B underpathological conditionswill facilitatetherapeutic development to treat brain disorders associated with TMEM106B.